PMID: 15381464Sep 24, 2004Paper

Treatment of relapses in aggressive non Hodgkin's lymphoma

Bulletin du cancer
André Bosly

Abstract

In spite of considerable progress in the initial treatment of aggressive non Hodgkin's lymphoma, patients in relapse have poor prognosis. Patients with refractory disease have an even worse outcome. Current strategies and published reports of relapsing patients are presented. Intensification of chemosensitive relapse has yielded a number of continuous second remissions. However considerable efforts are required to define when transplantation should be performed, which type of graft should be used, and what type of post-intensification therapy can be proposed to improve the remission rate and duration.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.